Skip to main content
. 2022 Feb 26;2022:5946670. doi: 10.1155/2022/5946670

Figure 1.

Figure 1

LINC00691 is overexpressed in B-CPAP cells, and LINC00691 inhibition attenuates B-CPAP cell proliferation. (a) qRT-PCR was performed to detect the expression of LINC00691 in PTC cells. (b) qRT-PCR was performed to evaluate the transfection efficiency in B-CPAP cells. (c) CCK-8 assay was performed to examine cell viability. Data are presented as the mean ± standard deviation (SD), n = 3, ∗p < 0.05. CTRL: control; NC: negative control of si-LINC00691; qRT-PCR: quantitative reverse transcription-polymerase chain reaction; PTC: papillary thyroid cancer.